Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study
Nutrients · 19.09.2025 · 17 (18) · 3003
DOI: 10.3390/nu17183003 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Nutrients, online erschienen am 19.09.2025. Verfasst von Rocío Puig und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Fatty Acids, Volatile, Feces, Prediabetic State. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Agencia Estatal de Investigación, Consolidación Investigadora 2022.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Gut microbiota is profoundly influenced by dysglycemic states, including prediabetes (preDM) and type 2 diabetes (T2D). Although short-chain fatty acids (SCFAs) may serve as proxies reflecting these microbial changes, their predictive role remains elusive. This study aimed to evaluate the association between fecal SCFA concentrations and glycemic status (preDM and T2D), using individuals with normoglycemia (NonDM) as the reference group in a Mediterranean adult population.
Methods
This study included a total of 88 participants from the Di@bet.es study who were classified into three groups according to the American Diabetes Association criteria: NonDM (45%), preDM (27%), and T2D (28%), respectively. We evaluated gut microbiota populations through massive sequencing and determined SCFAs concentration using gas chromatography–mass spectrometry. Adjusted multiple logistic regression models were used to estimate associations between SCFAs and metabolic status.
Results
The mean age of subjects with preDM and T2D was approximately 68 years, older than that of NonDM participants (about 60 years). About 50% of the subjects in the NonDM and preDM groups were female, whereas in the T2D group, females represented about 25%. The analysis revealed that only fecal acetic acid was significantly reduced in T2D compared to NonDM (p = 0.036) and preDM (p = 0.018) groups. Remarkably, fecal acetic acid was negatively associated with T2D risk when taking preDM as the reference state (OR = 0.561 [95% CI: 0.371–0.846], p = 0.009). Intriguingly, fecal acetic acid was identified as a significant positive predictor of preDM risk, taking the NonDM group as reference (OR = 1.422; p = 0.028), while propionic acid was inversely associated with preDM (OR = 0.714; p = 0.028).
Conclusions
Our analysis showed that fecal acetic acid levels were associated with a reduced risk of T2D but also with an increased risk of preDM; however, the biological relevance of these findings remains uncertain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
- Group of Endocrinology, Diabetes & Nutrition, Institut de Recerca Sant Pau (IR Sant Pau), Sant Quintí 77-79, 08041 Barcelona, Spain.
- Departament of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
- DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 08041 Barcelona, Spain.
- Endocrinology, Metabolism and Lipid Research Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
ORCID-Profile: Rocío Puig, Josep Julve, Esmeralda Castelblanco, Susana Amézqueta, Joan Vendrell, Josep Franch-Nadal, Dídac Mauricio, Sara Ramos-Romero
Förderung
- Instituto de Salud Carlos III
- Agencia Estatal de Investigación
- Consolidación Investigadora 2022
- CIBER-Consorcio Centro de Investigación Biomédica en Red en Diabetes y enfermedades meta-bólicas asociadas (CIBERDEM)
- PERIS program 2016-2018 (project Incidència de la diabetes tipus 2 a Catalunya (estudio di@bet.es)
- Spanish Ministry of Science and Innovation
- Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain)
- Instituto IDIAP Jordi Gol
Zitieren
APA
Puig, R., Rojo-López, M. I., Julve, J., Castelblanco, E., Ponomarenko, J., Amézqueta, S., Vendrell, J., Franch-Nadal, J., Torres, J. L., Mauricio, D., & Ramos-Romero, S. (2025). Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study. Nutrients, 17(18), 3003. https://doi.org/10.3390/nu17183003
Vancouver
Puig R, Rojo-López MI, Julve J, Castelblanco E, Ponomarenko J, Amézqueta S, et al. Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study. Nutrients. 2025;17(18):3003. doi:10.3390/nu17183003
BibTeX
@article{Puig2025,
author = {Puig, Rocío and Rojo-López, Marina Idalia and Julve, Josep and Castelblanco, Esmeralda and Ponomarenko, Julia and Amézqueta, Susana and Vendrell, Joan and Franch-Nadal, Josep and Torres, Josep Lluís and Mauricio, Dídac and Ramos-Romero, Sara},
title = {Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {18},
pages = {3003},
doi = {10.3390/nu17183003}
}
EUVIMED